Litcius/Paper detail

Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19

Giulia Monti, Giada Giovannini, Andrea Marudi, Roberta Bedin, Alessandra Melegari, Anna Maria Simone, Mario Santangelo, Alessandro Pignatti, Elisabetta Bertellini, Tommaso Trenti, Stefano Meletti

2020Seizure134 citationsDOIOpen Access PDF

Topics & Concepts

EncephalitisStatus epilepticusAutoimmune encephalitisAnti-NMDA receptor encephalitisCytokine stormMedicineCoronavirus disease 2019 (COVID-19)ImmunotherapyImmunologyVirologyEpilepsyImmune systemVirusPathologyDiseasePsychiatryInfectious disease (medical specialty)Long-Term Effects of COVID-19Autoimmune Neurological Disorders and TreatmentsCOVID-19 Clinical Research Studies
Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19 | Litcius